Lysinenorleucine

TargetMol
Product Code: TAR-T33069
Supplier: TargetMol
CodeSizePrice
TAR-T33069-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33069-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T33069-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Lysinenorleucine s a Lysine and hydroxylysine derivatives that can be used for the treatment of malignant and benign tumors.
CAS:
25612-46-8
Formula:
C12H25N3O4
Molecular Weight:
275.349
Purity:
0.98
SMILES:
N[C@@H](CCCCNCCCC[C@H](N)C(O)=O)C(O)=O

References

1. van den Nieuwendijk AM, Benningshof JC, Wegmann V, Bank RA, te Koppele JM, Brussee J, van der Gen A. Synthesis of reduced collagen crosslinks. Bioorg Med Chem Lett. 1999 Jun 21;9(12):1673-6. PubMed PMID: 10397498. 2. Nakamura Y, Okamoto K, Tanimura A, Kato M, Morimatsu M. Elastase digestion and biochemical analysis of the elastin from an elastofibroma. Cancer. 1986 Sep 1;58(5):1070-5. PubMed PMID: 3637115. 3. Nielsen CJ, Bentley JP, Marshall FJ. Age-related changes in reducible crosslinks of human dental pulp collagen. Arch Oral Biol. 1983;28(8):759-64. PubMed PMID: 6579908. 4. Liu Y, Springer IN, Zimmermann CE, A?il Y, Scholz-Arens K, Wiltfang J, Terheyden H. Missing osteogenic effect of expanded autogenous osteoblast-like cells in a minipig model of sinus augmentation with simultaneous dental implant installation. Clin Oral Implants Res. 2008 May;19(5):497-504. doi: 10.1111/j.1600-0501.2007.01504.x. Epub 2008 Mar 26. PubMed PMID: 18371097.